formestane has been researched along with Prostatic Neoplasms in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ajduković, JJ; Celić, AS; Djurendić, EA; Gaši, KM; Jakimov, DS; Klisurić, OR; Petri, ET; Sakač, MN | 1 |
| Ćelić, AS; Djurendić, EA; Jakimov, DS; Klisurić, OR; Nikolić, AR; Penov Gaši, KM; Petri, ET; Sakač, MN | 1 |
| Abderrahman, B; Jordan, VC | 1 |
| McTavish, D; Wiseman, LR | 1 |
| Block, JL; Block, NL; Lokeshwar, BL | 1 |
| Davies, JH; Heeremans, CE; Jarman, M; McCague, R; Niessen, WM; Poon, GK; van der Greef, J; van der Hoeven, RA | 1 |
| Coombes, RC; Davies, JH; Dowsett, M; Hedley, A; Jacobs, S; Shearer, RJ | 1 |
| Coombes, RC; Cunningham, D; Davies, JH; Dowsett, M; Hedley, A; Malone, PR; Shearer, RJ | 1 |
| Banks, PK; Brodie, AM; Inkster, SE; Koos, RD; Son, C | 1 |
| Brodie, AM; Inkster, SE; King, DA; Meyer, KM; Son, C | 1 |
| Fair, WR; Fishman, J; Laudone, VP; Stone, NN | 1 |
2 review(s) available for formestane and Prostatic Neoplasms
| Article | Year |
|---|---|
Formestane. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of breast cancer and prostatic cancer.
Topics: Androstenedione; Animals; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; In Vitro Techniques; Male; Prostatic Neoplasms | 1993 |
Aromatase and other inhibitors in breast and prostatic cancer.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Estrogen Antagonists; Humans; Male; Prostatic Neoplasms | 1990 |
2 trial(s) available for formestane and Prostatic Neoplasms
| Article | Year |
|---|---|
Aromatase inhibition: 4-hydroxyandrostenedione (4-OHA, CGP 32349) in advanced prostatic cancer.
Topics: Aged; Androstenedione; Aromatase Inhibitors; Dihydrotestosterone; Estradiol; Humans; Male; Neoplasm Staging; Prostatic Neoplasms; Testosterone; Time Factors | 1992 |
Aromatase inhibition in advanced prostatic cancer: preliminary communication.
Topics: Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Clinical Trials as Topic; Humans; Male; Middle Aged; Prostatic Neoplasms | 1990 |
7 other study(ies) available for formestane and Prostatic Neoplasms
| Article | Year |
|---|---|
17(E)-picolinylidene androstane derivatives as potential inhibitors of prostate cancer cell growth: antiproliferative activity and molecular docking studies.
Topics: Androstanes; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Humans; Male; Molecular Docking Simulation; Prostate; Prostatic Neoplasms; Protein Binding; Steroid 17-alpha-Hydroxylase | 2013 |
Synthesis and anticancer cell potential of steroidal 16,17-seco-16,17a-dinitriles: identification of a selective inhibitor of hormone-independent breast cancer cells.
Topics: Antineoplastic Agents; Aromatase; Breast; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Estrogen Receptor alpha; Female; HeLa Cells; Humans; Male; Molecular Docking Simulation; Nitriles; Prostate; Prostatic Neoplasms; Steroids | 2015 |
Angela M. Hartley Brodie (1934-2017).
Topics: Androstadienes; Androstenedione; Aromatase Inhibitors; Benzimidazoles; Breast Neoplasms; Estrogens; Female; History, 20th Century; History, 21st Century; Humans; Male; Maryland; Prostatic Neoplasms | 2017 |
Inhibition of aromatase activity and growth suppression by 4-methoxy-4-androstene-3,17-dione in an androgen sensitive human prostatic carcinoma cell line.
Topics: Androstenedione; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Cell Division; Culture Media, Serum-Free; Drug Screening Assays, Antitumor; Humans; Male; Prostatic Neoplasms; Testosterone; Tumor Cells, Cultured | 1996 |
Identification of 4-hydroxyandrost-4-ene-3,17-dione metabolites in prostatic cancer patients by liquid chromatography-mass spectrometry.
Topics: Androstenedione; Chromatography, High Pressure Liquid; Humans; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Prostatic Neoplasms; Spectrophotometry, Ultraviolet | 1992 |
Lack of evidence for aromatase in human prostatic tissues: effects of 4-hydroxyandrostenedione and other inhibitors on androgen metabolism.
Topics: Androstenedione; Aromatase; Cholestenone 5 alpha-Reductase; Estrogens; Humans; In Vitro Techniques; Male; Oxidoreductases; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1989 |
Aromatization of androstenedione to estrogen by benign prostatic hyperplasia, prostate cancer and expressed prostatic secretions.
Topics: Androstenedione; Carrier Proteins; Dose-Response Relationship, Drug; Estrogens; Humans; Hyperplasia; Male; Prostate; Prostatic Neoplasms; Prostatic Secretory Proteins | 1987 |